Intco Medical Technology (300677.SZ) plans to spend 80-120 million yuan to repurchase shares.
Yingke Medical (300677.SZ) announcement, the company plans to use its own funds to repurchase a portion through centralized bidding...
Intco Medical Technology (300677.SZ) announced that the company plans to use its own funds to repurchase some of its company shares through centralized bidding trading (RMB ordinary shares (A shares)) for the implementation of an employee stock ownership plan and/or equity incentive. The total amount of repurchase funds will not be less than RMB 80 million (inclusive) and not more than RMB 120 million (inclusive), with a repurchase price limit of RMB 26.66 per share (inclusive).
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


